HK1042478A1 - 2-oxo-2h-quinoline derivatives - Google Patents
2-oxo-2h-quinoline derivativesInfo
- Publication number
- HK1042478A1 HK1042478A1 HK02102249.3A HK02102249A HK1042478A1 HK 1042478 A1 HK1042478 A1 HK 1042478A1 HK 02102249 A HK02102249 A HK 02102249A HK 1042478 A1 HK1042478 A1 HK 1042478A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oxo
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19839499A DE19839499A1 (en) | 1998-08-29 | 1998-08-29 | 2-oxo-2H-quinoline derivatives |
| PCT/EP1999/005315 WO2000012479A1 (en) | 1998-08-29 | 1999-07-26 | 2-oxo-2h-quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1042478A1 true HK1042478A1 (en) | 2002-08-16 |
Family
ID=7879227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK02102249.3A HK1042478A1 (en) | 1998-08-29 | 2002-03-25 | 2-oxo-2h-quinoline derivatives |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1107954A1 (en) |
| JP (1) | JP2002523494A (en) |
| KR (1) | KR20010072862A (en) |
| CN (1) | CN1315942A (en) |
| AR (1) | AR021782A1 (en) |
| AU (1) | AU5164199A (en) |
| BR (1) | BR9913140A (en) |
| CA (1) | CA2342230A1 (en) |
| DE (1) | DE19839499A1 (en) |
| HK (1) | HK1042478A1 (en) |
| HU (1) | HUP0103212A3 (en) |
| ID (1) | ID27863A (en) |
| NO (1) | NO20010996L (en) |
| PL (1) | PL346045A1 (en) |
| SK (1) | SK2652001A3 (en) |
| WO (1) | WO2000012479A1 (en) |
| ZA (1) | ZA200102565B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1569912E (en) | 2002-12-03 | 2015-09-15 | Pharmacyclics Llc | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| SG10201900631TA (en) | 2014-08-01 | 2019-02-27 | Nuevolution As | Compounds active towards bromodomains |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4070470A (en) * | 1974-06-24 | 1978-01-24 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting carbostyrils, their compositions and method of use |
| IE43079B1 (en) * | 1975-03-20 | 1980-12-17 | Ici Ltd | Quinolone derivatives |
| JPS596858B2 (en) * | 1975-04-30 | 1984-02-15 | オオツカセイヤク カブシキガイシヤ | Method for producing 3,4-dihydrocarbostyryl derivative |
| AT347956B (en) * | 1976-03-18 | 1979-01-25 | Ici Ltd | Process for the preparation of new quinol-2-on-4-yl-alkanoic acids and their base addition salts |
| DE2651581A1 (en) * | 1976-11-12 | 1978-05-18 | Merck Patent Gmbh | CHINOLONE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
| WO1992004328A1 (en) * | 1990-09-07 | 1992-03-19 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
| ATE161252T1 (en) * | 1990-09-07 | 1998-01-15 | Schering Corp | ANTIVIRAL AND ANTIHYPERTENSIVE COMPOUNDS |
| ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| DE4208304A1 (en) * | 1992-03-16 | 1993-09-23 | Merck Patent Gmbh | 2-OXOCHINOLINDERIVATE |
| IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| DE19528418A1 (en) * | 1995-08-02 | 1997-02-06 | Merck Patent Gmbh | Endothelin receptor antagonists |
| DE19530996A1 (en) * | 1995-08-23 | 1997-02-27 | Boehringer Mannheim Gmbh | Cyclic guanidines, process for their preparation and pharmaceuticals |
| US5968959A (en) * | 1997-12-12 | 1999-10-19 | Orion Corporation | Method for the prevention and treatment of stunned myocardium |
-
1998
- 1998-08-29 DE DE19839499A patent/DE19839499A1/en not_active Withdrawn
-
1999
- 1999-07-26 CN CN99810283A patent/CN1315942A/en active Pending
- 1999-07-26 HU HU0103212A patent/HUP0103212A3/en unknown
- 1999-07-26 ID IDW20010680A patent/ID27863A/en unknown
- 1999-07-26 AU AU51641/99A patent/AU5164199A/en not_active Abandoned
- 1999-07-26 SK SK265-2001A patent/SK2652001A3/en unknown
- 1999-07-26 BR BR9913140-4A patent/BR9913140A/en not_active Application Discontinuation
- 1999-07-26 CA CA002342230A patent/CA2342230A1/en not_active Abandoned
- 1999-07-26 EP EP99936606A patent/EP1107954A1/en not_active Withdrawn
- 1999-07-26 JP JP2000567512A patent/JP2002523494A/en active Pending
- 1999-07-26 PL PL99346045A patent/PL346045A1/en unknown
- 1999-07-26 WO PCT/EP1999/005315 patent/WO2000012479A1/en not_active Application Discontinuation
- 1999-07-26 KR KR1020017002261A patent/KR20010072862A/en not_active Application Discontinuation
- 1999-08-27 AR ARP990104301A patent/AR021782A1/en unknown
-
2001
- 2001-02-27 NO NO20010996A patent/NO20010996L/en not_active Application Discontinuation
- 2001-03-28 ZA ZA200102565A patent/ZA200102565B/en unknown
-
2002
- 2002-03-25 HK HK02102249.3A patent/HK1042478A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002523494A (en) | 2002-07-30 |
| DE19839499A1 (en) | 2000-03-02 |
| PL346045A1 (en) | 2002-01-14 |
| HUP0103212A3 (en) | 2002-06-28 |
| NO20010996D0 (en) | 2001-02-27 |
| AU5164199A (en) | 2000-03-21 |
| ZA200102565B (en) | 2002-06-28 |
| CN1315942A (en) | 2001-10-03 |
| BR9913140A (en) | 2001-05-08 |
| AR021782A1 (en) | 2002-08-07 |
| KR20010072862A (en) | 2001-07-31 |
| SK2652001A3 (en) | 2001-09-11 |
| WO2000012479A1 (en) | 2000-03-09 |
| EP1107954A1 (en) | 2001-06-20 |
| ID27863A (en) | 2001-04-26 |
| HUP0103212A2 (en) | 2002-05-29 |
| CA2342230A1 (en) | 2000-03-09 |
| NO20010996L (en) | 2001-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL141226A0 (en) | 1h-imidazopyridine derivatives | |
| PL345540A1 (en) | Thiobenzimidazole derivatives | |
| SG71898A1 (en) | Benzosulfone derivatives | |
| EG24081A (en) | 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives | |
| HUP0003642A3 (en) | N-alkanoylphenylalanine derivatives | |
| GB9702194D0 (en) | Sulphonide derivatives | |
| ZA987602B (en) | N-alkanoylphenylalanine derivatives | |
| GB9910384D0 (en) | Alpha-ketoamide derivatives | |
| HUP9801168A3 (en) | Triazinylaminostilbene derivatives | |
| EG23802A (en) | 2-Phenylpyran-4-one derivatives | |
| IL132982A0 (en) | Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives | |
| GB9715821D0 (en) | Amidino-camptothecin derivatives | |
| GB2321457B (en) | 5-Aroylnaphthalene derivatives | |
| GB9827729D0 (en) | Thieno-indole derivatives | |
| GB9701628D0 (en) | Imino-aza-anthracyclinone derivatives | |
| GB9725541D0 (en) | Amino-benzothiazole derivatives | |
| EP1061912A4 (en) | Phenanthrofuran derivatives | |
| ZA983116B (en) | Arylsecocholadiene derivatives | |
| IL139276A0 (en) | Cyclohexenondioxthio chromanoyl derivatives | |
| HK1042478A1 (en) | 2-oxo-2h-quinoline derivatives | |
| IL131159A0 (en) | 4-Aminoethoxyindazole derivatives | |
| GB9816279D0 (en) | Arylthiazolidinedione derivatives | |
| SI1051395T1 (en) | N-hydroxyformamide derivatives | |
| GB9706753D0 (en) | Aralkoxy-morphinan derivatives | |
| SI1005445T1 (en) | N-alkanoylphenylalanine derivatives |